Skip to content
Menu

Allogene Therapeutics, Inc. ALLO

Full chart Compare
Set alert

Price alert · ALLO

All alert types
0.63 USD -0.04 (-5.88%)

Regular-session close

0.63 +0.01 +1.12%

After hours · Nov 20, 7:37 PM ET

0.6192 Day range 0.67
0.6277 52-week range 3.06
YTD
-54.18%
1 year
-49.38%

Revenue & Expenses

Revenue Profit Costs
Other Income$16.05MGross Profit$22.00KNet Loss$257.59MExpenses$273.66MSelling, General & Admin$65.20MResearch & Development$192.30MOther Operating Expenses$15.72MIncome Tax$443.00KRevenue$22.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

ALLO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-209.31M-273.20M-327.74M-335.54M-180.19M
-190.89M-257.59M-327.26M-340.41M-182.05M
-0.87-1.32-2.09-2.38-1.34
ALLO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
61.98M85.51M93.45M72.20M183.61M
415.90M548.71M642.84M821.58M1.05B
123.36M126.53M130.60M154.70M125.63M
292.54M422.18M512.23M666.88M925.20M
ALLO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-149.25M-200.30M-237.73M-220.52M-184.81M
95.56M75.69M163.29M106.16M163.66M
30.16M116.67M95.69M2.95M11.96M
-386.00K-694.00K-1.52M-5.19M-21.45M
-23.53M-7.94M21.25M-111.41M-9.19M